About
Septodont is a French pharmaceutical and medical device company founded in 1932, specializing in dental consumables. Headquartered in Saint-Maur-des-Fossés, France, it operates globally in over 110 countries and remains a 100% family-owned business led by CEO Olivier Schiller. The company has a rich history of innovation, particularly in dental anesthesia, and has expanded its product offerings to include bioactive and biocompatible therapeutic solutions. The product range includes dental anesthesia solutions such as topical and local anesthetics, safety devices, and the flagship product, Septocaine, known for its rapid onset and effectiveness. Septodont also provides endodontic and restorative materials, as well as products for tissue regeneration and surgical applications. Additionally, the company acts as a Contract Development Manufacturing Organization (CDMO) and collaborates with other firms through its subsidiary, Novocol Healthcare, to enhance healthcare solutions. With ambitious growth goals, Septodont aims to reach €1 billion in revenue by its 100th anniversary in 2032.
Technologies
Keywords
Company Information
-
Employees 1900
-
Founded 1932
-
Annual Revenue $393000000
Location
58 Rue du Pont de Creteil, Saint-Maur-des-Fosses, Ile-de-France, France, 94100
